SAN MATEO, Calif., April 24 /PRNewswire-FirstCall/ -- NeurogesX, Inc.
(Nasdaq: NGSX), a biopharmaceutical company focused on developing novel
pain management therapies, announced today that it is scheduled to present
on Wednesday, April 30, 2008 at the Morgan Stanley Global Healthcare
Unplugged Conference. Anthony DiTonno, President and Chief Executive
Officer, will be presenting and Stephen Ghiglieri, Chief Financial Officer,
will be available to respond to questions.
Event: 2008 Morgan Stanley Global Healthcare Unplugged Conference
Date: Wednesday, April 30, 2008
Time: 2:20 p.m. ET
Place: Ritz Carlton in Key Biscayne, Florida
An audio Web cast of the Company's presentations will be available by going to the investor relations section of NeurogesX' Web site at http://www.neurogesx.com. A replay of the presentation will be available for 15 days.
About NeurogesX, Inc.
NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on
developing and commercializing novel pain management therapies. Its initial
focus is on chronic peripheral neuropathic pain, including postherpetic
neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and
painful diabetic neuropathy. NeurogesX' late stage product portfolio is led
by its product candidate NGX-4010, a dermal patch designed to manage pain
associated with peripheral neuropathic pain conditions, that the company
believes offers significant
|SOURCE NeurogesX, Inc.|
Copyright©2008 PR Newswire.
All rights reserved